Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1607 clinical trials
Study of Efficacy and Safety of Valproic Acid in Chronic Lymphocytic Leukemia (CLL)

The purpose of this study is to determine whether Valproic acid, as a single agent is effective in the treatment of Chronic Lymphocytic Leukemia which has relapsed or is refractory to

cancer
platelet count
lymphoid leukemia
neutrophil count
nucleoside analog
  • 22 views
  • 07 Nov, 2020
  • 1 location
The Humanized Monoclonal Antibody Milatuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)

The purpose of this study is to determine whether Milatuzumab is effective in patients with refractory chronic lymphocytic leukemia, and also to find out in which range of doses is a

lymphadenopathy
monoclonal antibodies
cytopenia
monoclonal protein
lymphoid leukemia
  • 20 views
  • 07 Nov, 2020
  • 1 location
Efficacy and Safety of Nipent Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

This research study measures the safety and efficacy of the combination of three drugs that are approved, Nipent, Rituxan and Cytoxan in the treatment of Chronic Lymphocytic Leukemia (CLL

rituxan
lymphoid leukemia
  • 389 views
  • 07 Nov, 2020
  • 1 location
Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid Leukaemia

acute myeloid leukaemia (AML) of the adult for the patients of less than 55 years, because it offers chances of cure higher than chemotherapy or the auto-graft. However, mortality related to

cyclophosphamide
total body irradiation
secondary acute myeloid leukemia
remission
idarubicin
  • 18 views
  • 07 Nov, 2020
  • 1 location
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia

The purpose of this study is to determine whether NRX 195183 is effective in the treatment of relapsed or refractory Acute Promyelocytic Leukemia

tretinoin
cytotoxic chemotherapy
arsenic
nrx 195183
  • 7 views
  • 07 Nov, 2020
  • 1 location
Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B7.1 (CD80) and IL-2

The purpose of this study is to assess the safety and tolerability of an 'AML Cell Vaccine' in patients with poor prognosis acute myeloid leukaemia (AML).

graft versus host disease
remission
  • 17 views
  • 07 Nov, 2020
  • 1 location
Cladribine Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)

The purpose of this study is to evaluate the safety and the efficacy of cladribine, high-dose cytarabine and idarubicin in the treatment of patients with relapsed acute myeloid leukemia.

idarubicin
cladribine
cytarabine
remission
  • 14 views
  • 07 Nov, 2020
  • 1 location
Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia

There is very limited data on the use of arsenic trioxide in newly diagnosed patients with acute promyelocytic leukemia. The use of arsenic trioxide was limited to relapsed patients

hepatic toxicity
tretinoin
arsenic
remission
  • 76 views
  • 07 Nov, 2020
  • 8 locations
Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

in patients with refractory or relapsed acute lymphocytic leukemia.

lymphoid leukemia
  • 26 views
  • 07 Nov, 2020
  • 1 location
Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)

The purpose of this study is to investigate the efficacy and safety for treating adult ALL patients with the pediatric protocol.

mercaptopurine
asparaginase
ejection fraction
cyclophosphamide
methotrexate
  • 7 views
  • 07 Nov, 2020
  • 1 location